Pfizer Inc. Drug Tricks Immune System to Shrink Pancreatic Tumors in Research

March 25, 2011 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Bloomberg -- An experimental drug made by Pfizer Inc. (PFE) slowed deadly pancreatic cancer in a study that revealed a new treatment approach that tricks the immune system to attack tissue protecting tumors, researchers said.

Twitter
LinkedIn
Facebook
Email
Print

Clinical research Phase 2

Pfizer